US EditionCurrent Landscape of Vector Safety and Genotoxicity after Hematopoietic Stem or Immune Cell Gene Therapy
Summary by Stemwell Science News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
FAQs : Gene Therapy Approved for sickle cell disorder » Sickle Cell Society
Casgevy on the NHS for treating sickle cell disorder, and FAQ update. 31 January 2025. Updated 9 April 2025 Updated information : Frequently asked questions for patients and the public on Casgevy/Exa-cel for sickle cell – are now available, produced in collaboration with our partners on this campaign, at the Anthony Nolan Charity. Download them HERE We are delighted to let you know that NICE has today approved the ground-breaking gene thera…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
